145 related articles for article (PubMed ID: 2361735)
1. Prevalence of tri- and tetraantennary glycans of human alpha 1-acid glycoprotein in release of macrophage inhibitor of interleukin-1 activity.
Bories PN; Feger J; Benbernou N; Rouzeau JD; Agneray J; Durand G
Inflammation; 1990 Jun; 14(3):315-23. PubMed ID: 2361735
[TBL] [Abstract][Full Text] [Related]
2. Glycosylation of three molecular forms of human alpha 1-acid glycoprotein having different interactions with concanavalin A. Variations in the occurrence of di-, tri-, and tetraantennary glycans and the degree of sialylation.
Bierhuizen MF; De Wit M; Govers CA; Ferwerda W; Koeleman C; Pos O; Van Dijk W
Eur J Biochem; 1988 Aug; 175(2):387-94. PubMed ID: 3402460
[TBL] [Abstract][Full Text] [Related]
3. A macrophage-derived factor induced by alpha 1-acid glycoprotein that inhibits IL-1 comitogenic activity.
Bories PN; Kodari E; Feger J; Rouzeau JD; Agneray J; Durand G
Immunol Lett; 1990 Oct; 26(1):105-10. PubMed ID: 2276760
[TBL] [Abstract][Full Text] [Related]
4. Intact Human Alpha-Acid Glycoprotein Analyzed by ESI-qTOF-MS: Simultaneous Determination of the Glycan Composition of Multiple Glycosylation Sites.
Baerenfaenger M; Meyer B
J Proteome Res; 2018 Nov; 17(11):3693-3703. PubMed ID: 30295034
[TBL] [Abstract][Full Text] [Related]
5. Human alpha 1-acid glycoprotein-exposed macrophages release interleukin 1 inhibitory activity.
Bories PN; Guenounou M; Féger J; Kodari E; Agneray J; Durand G
Biochem Biophys Res Commun; 1987 Sep; 147(2):710-5. PubMed ID: 3498488
[TBL] [Abstract][Full Text] [Related]
6. Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera.
De Graaf TW; Van der Stelt ME; Anbergen MG; van Dijk W
J Exp Med; 1993 Mar; 177(3):657-66. PubMed ID: 7679706
[TBL] [Abstract][Full Text] [Related]
7. Alpha 1-acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by human monocytes and alveolar and peritoneal macrophages.
Boutten A; Dehoux M; Deschenes M; Rouzeau JD; Bories PN; Durand G
Eur J Immunol; 1992 Oct; 22(10):2687-95. PubMed ID: 1396973
[TBL] [Abstract][Full Text] [Related]
8. Detailed structural features of glycan chains derived from alpha1-acid glycoproteins of several different animals: the presence of hypersialylated, O-acetylated sialic acids but not disialyl residues.
Nakano M; Kakehi K; Tsai MH; Lee YC
Glycobiology; 2004 May; 14(5):431-41. PubMed ID: 14736726
[TBL] [Abstract][Full Text] [Related]
9. Glycoprotein analysis using lectin microcolumns and capillary electrophoresis: Characterization of alpha
Zhang C; Schumacher KN; Dodds ED; Hage DS
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122855. PubMed ID: 34274643
[TBL] [Abstract][Full Text] [Related]
10. Glycan variants of human alpha 1-acid glycoprotein modulate the biology of macrophages. Evidence that a concanavalin A-unreactive variant is involved in the production of an interleukin 1 inhibitor.
Durand G
Prog Clin Biol Res; 1989; 300():247-65. PubMed ID: 2789389
[No Abstract] [Full Text] [Related]
11. Recombinant human interleukin 1 beta and tumor necrosis factor affect glycosylation of serum alpha 1-acid glycoprotein in rats.
Poüs C; Chauvelot-Moachon L; Lecoustillier M; Durand G
Inflammation; 1992 Jun; 16(3):197-203. PubMed ID: 1500096
[TBL] [Abstract][Full Text] [Related]
12. Alterations of N-glycan branching and expression of sialic acid on amniotic fluid alpha-1-acid glycoprotein derived from second and third trimesters of normal and prolonged pregnancies.
Orczyk-Pawiłowicz M; Hirnle L; Katnik-Prastowska I
Clin Chim Acta; 2006 May; 367(1-2):86-92. PubMed ID: 16405881
[TBL] [Abstract][Full Text] [Related]
13. Microheterogeneity of alpha 1-acid glycoprotein in early and established rheumatoid arthritis.
Hrycaj P; Sobieska M; Mackiewicz S; Müller W
J Rheumatol; 1993 Dec; 20(12):2020-4. PubMed ID: 8014928
[TBL] [Abstract][Full Text] [Related]
14. Con A-nonreactive human alpha 1-acid glycoprotein (AGP) is more effective in modulation of lymphocyte proliferation than Con A-reactive AGP serum variants.
Pos O; Oostendorp RA; van der Stelt ME; Scheper RJ; Van Dijk W
Inflammation; 1990 Apr; 14(2):133-41. PubMed ID: 2323809
[TBL] [Abstract][Full Text] [Related]
15. Con A affinity of rat alpha 1-acid glycoprotein (rAGP): changes during inflammation, dexamethasone or phenobarbital treatment as detected by crossed affino immunoelectrophoresis (CAIE) are not only a reflection of biantennary glycan content.
Pos O; Drechou A; Durand G; Bierhuizen MF; van der Stelt ME; van Dijk W
Clin Chim Acta; 1989 Sep; 184(2):121-31. PubMed ID: 2481574
[TBL] [Abstract][Full Text] [Related]
16. Modifications of concanavalin A patterns of alpha 1-acid glycoprotein and alpha 2-HS glycoprotein in alcoholic liver disease.
Jezequel M; Seta NS; Corbic MM; Feger JM; Durand GM
Clin Chim Acta; 1988 Aug; 176(1):49-57. PubMed ID: 3168293
[TBL] [Abstract][Full Text] [Related]
17. The degree of branching of the glycans of alpha(1)-acid glycoprotein in asthma. A correlation with lung function and inflammatory parameters.
Van Den Heuvel MM; Poland DC; De Graaff CS; Hoefsmit EC; Postmus PE; Beelen RH; Van Dijk W
Am J Respir Crit Care Med; 2000 Jun; 161(6):1972-8. PubMed ID: 10852776
[TBL] [Abstract][Full Text] [Related]
18. Alterations of the glycan moiety of human alpha 1-acid glycoprotein in late-term pregnancy.
Biou D; Bauvy C; N'Guyen H; Codogno P; Durand G; Aubery M
Clin Chim Acta; 1991 Dec; 204(1-3):1-12. PubMed ID: 1819453
[TBL] [Abstract][Full Text] [Related]
19. Effect of transgenic expression of human alpha 1-acid glycoprotein (AGP) on the glycosylation of human and mouse AGP in various transgenic mouse sera.
van Dijk W; van der Stelt ME; Salera A; Dente L
Eur J Cell Biol; 1991 Jun; 55(1):143-8. PubMed ID: 1717269
[TBL] [Abstract][Full Text] [Related]
20. Role of biantennary glycans and genetic variants of human alpha1-acid glycoprotein in enantioselective binding of basic drugs as studied by high performance frontal analysis/capillary electrophoresis.
Kuroda Y; Kita Y; Shibukawa A; Nakagawa T
Pharm Res; 2001 Mar; 18(3):389-93. PubMed ID: 11442281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
